Cell and Gene Therapy
|
Mycenax offers a comprehensive, one-stop CRDMO service covering a broad spectrum of Cell and Gene Therapy (CGT) product types. We are committed to delivering total solutions that facilitate feasibility study, process development and GMP manufacturing of innovative CGT products, enabling our clients to expedite their products to market through our state-of-the-art CRDMO services. |
||||||
|
360° CGT Total Solutions: Accelerating Your CGT Journey from Discovery to Commercialization |
||||||
 |
||||||
|
Comprehensive CGT Modalities |
||||||
|
Mycenax’s CGT platforms covering Immune cell, MSC, and Exosome modalities, enabling flexible and scalable solutions for diverse cell therapy needs. |
||||||
 |
||||||
  |
||||||
|
End-to-End Phase Appropriate Solutions |
||||||
|
Accelerate and streamline your path from research to clinical application. We support you from development to production with a clear and efficient process. |
||||||
 |
||||||
|
Tailored Solutions with State-of-the-Art Facilities |
||||||
|
Our CGT platform features advanced equipment including the Ambr® 250 mini-bioreactor, Bench-top bioreactor, AKTA purification, and automated single-use centrifuge systems, ensuring safe, efficient, and high-quality cell processing from culture to cryopreservation. |
||||||
 |
 |
 |
||||
|
Mycenax offers a comprehensive, one-stop CRDMO service covering a broad spectrum of Cell and Gene Therapy (CGT) product types. We are committed to delivering total solutions that facilitate feasibility study, process development and GMP manufacturing of innovative CGT products, enabling our clients to expedite their products to market through our state-of-the-art CRDMO services. |
||||||
|
360° CGT Total Solutions: Accelerating Your CGT Journey from Discovery to Commercialization |
||||||
|
||||||
|
Comprehensive CGT Modalities |
||||||
|
Mycenax’s CGT platforms covering Immune cell, MSC, and Exosome modalities, enabling flexible and scalable solutions for diverse cell therapy needs. |
||||||
 |
||||||
 |
||||||
 |
||||||
|
|
||||||
|
|
||||||
|
End-to-End Phase Appropriate Solutions |
||||||
|
Accelerate and streamline your path from research to clinical application. We support you from development to production with a clear and efficient process. |
||||||
 |
||||||
 |
||||||
 |
||||||
|
Tailored Solutions with State-of-the-Art Facilities |
||||||
|
Our CGT platform features advanced equipment including the Ambr® 250 mini-bioreactor, Bench-top bioreactor, AKTA purification, and automated single-use centrifuge systems, ensuring safe, efficient, and high-quality cell processing from culture to cryopreservation. |
||||||
|
||||||
|
||||||
|
||||||
|
|
||||||
|
||||||
|
||||||